Phase 2 study of pembrolizumab in patients with advanced rare cancersAung Naing, Mouhammed Amir Habra, Sarina A. Piha‐Paul et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 130
PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variantsKathleen Baysac, Michael J. Ombrello, Ankur Kumar Jindal et al.|Journal of Allergy and Clinical Immunology|2023Cited by 53